Patent application number | Description | Published |
20080292645 | Antibody or Antibody Fragment Coupled with an Immunogenic Agent - An immunogenic conjugate includes a target cell-specific circulating molecule and at least one immunogenic agent, the immunogenic agent being coupled by any appropriate means with the circulating molecule. Also described is a method for preparing the immunogenic conjugate and its use for treating cancers or autoimmune diseases. | 11-27-2008 |
20080317860 | Use of a Polysaccharide Which is Excreted by the Vibrio Diabolicus Species For the Engineering of Non-Mineralized Connective Tissue - The invention relates to the use of a polysaccharide which is excreted by the | 12-25-2008 |
20090028924 | USE OF A POLYSACCHARIDE WHICH IS EXCRETED BY THE VIBRIO DIABOLICUS SPECIES FOR THE REGENERATION AND PROTECTION OF THE PERIODONTIUM - The invention relates to the use of a polysaccharide which is excreted by the | 01-29-2009 |
20110245199 | Sulfated Depolymerized Derivatives of Expolysaccharides (Eps) from Mesophilic Marine Bacteria, Method for Preparing the Same, and Uses Thereof in Tissue Regeneration - The invention relates to certain low-molecular weight sulphated polysaccharide derivatives of marine native exopolysaccharides (EPSs) excreted by mesophilic marine bacteria from a deep hydrothermal environment, wherein said derivatives can be obtained by means of a method which comprises a step of free radical depolymerisation of said native EPSs followed by a step of sulphating the resulting depolymerised derivatives. The present invention further relates to the use of said low-molecular weight sulphated polysaccharide derivatives as a wound-healing agent, particularly for preparing pharmaceutical compositions suitable for treating or preventing diseases of the connective tissues and particularly skin and gum tissues. The figure demonstrates how polysaccharide derivative GY 785 DRS according to the invention can stimulate fibroblast proliferation in latticed or reconstructed connective tissues at a concentration of 10 μg (m) g/ml. | 10-06-2011 |
20110305647 | USE OF A POLYSACCHARIDE WHICH IS EXCRETED BY THE VIBRIO DIABOLICUS SPECIES FOR THE REGENERATION AND PROTECTION OF THE PERIODONTIUM - The invention relates to the use of a polysaccharide which is excreted by the | 12-15-2011 |
20130108819 | EXOPOLYSACCHARIDES FOR PREVENTING AND CONTROLLING THE FORMATION OF BIOFILMS | 05-02-2013 |
20130152865 | NUCLEUS COATED WITH A FILM-FORMING COATING HAVING ANTIBACTERIAL AND CICATRIZING PROPERTIES, AND METHOD FOR OBTAINING SAME - A nucleus coated with a film includes one or more exopolysaccharides (EPS) and optionally one or more bioactive molecules such as bactericidal or bacteriostatic agents, cicatrizing agents and/or anti-inflammatory agents. A method for obtaining the nucleus, in order to inhibit graft rejection in pearl oysters is also described. | 06-20-2013 |
20130263793 | NUCLEUS COVERED WITH PHA - The present invention relates to a nucleus covered or coated with a film including one or more PHA. The invention also relates to a PHA, characterized in that it is of the type PHB-V, a film and a composition including the PHA. The invention further relates to a film or a composition including a PHA and zosteric acid or a bioactive molecule. The invention moreover relates to a surface, preferably a nucleus, covered with the film of PHA, a method for production thereof, and methods for grafting a pearl oyster and producing a pearl using this nucleus. Finally, the present invention relates to a method for reducing graft failure and/or for improving the quality of the pearl using the nucleus according to the invention. | 10-10-2013 |
20140037597 | Sulfated Depolymerized Derivatives of Exopolysaccharides (EPS) From Mesophilic Marine Bacteria, Method For Preparing Same, And Uses Thereof In Tissue Regeneration - The invention relates to certain low-molecular weight sulphated polysaccharide derivatives of marine native exopolysaccharides (EPSs) excreted by mesophilic marine bacteria from a deep hydrothermal environment, wherein said derivatives can be obtained by means of a method which comprises a step of free radical depolymerisation of said native EPSs followed by a step of sulphating the resulting depolymerised derivatives. The present invention further relates to the use of said low-molecular weight sulphated polysaccharide derivatives as a wound-healing agent, particularly for preparing pharmaceutical compositions suitable for treating or preventing diseases of the connective tissues and particularly skin and gum tissues. The figure demonstrates how polysaccharide derivative GY 785 DRS according to the invention can stimulate fibroblast proliferation in latticed or reconstructed connective tissues at a concentration of 10 μg (m) g/ml. | 02-06-2014 |